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Telomerase is a ribonucleoprotein that maintains the telomeric
ends of chromosomes during replication by adding short stretches
of nucleotide repeats using a portion of its integral RNA compo-
nent as the template. This book is a collection of papers presented
at a symposium on telomeres and telomerase held at the Ciba
Foundation in February 1997, and it is claimed to be state-of-the-
art at that time. The volume is constructed in an interesting way,
with individual papers from an international group of experts
followed by discussion, but in addition to this there are four
general discussion chapters. The first half of the book is concerned
exclusively with the use of non-mammalian systems and models to
dissect the role of telomerase.
Blackburn and colleagues give a short review of the interaction
of telomeres and telomerase. They suggest that altering telomeric
DNA rather than simply loss of telomeric DNA can block nuclear
division and, because synthesis of the correct telomeric DNA
sequence is dependent on the telomerase RNA structure, it may be
possible in the future to induce changes in telomerase RNA that
will cause it to make deleterious telomeres, representing a possible
remedy for cancer or other pathogenic cell proliferation. They also
point out the likelihood that in mammalian cells telomere length
may be negatively regulated by the Rap1p-like telomere binding
factor TRF1, so it is important to consider other factors besides
telomerase levels as determinants of telomere length maintenance
in human cells.
Cech and Lingner review the DNA end replication problem and
discuss ciliate telomerase and the use of ciliate models for under-
standing the solution to the problem. Hughes et al describe the role
of the EST genes in yeast telomere replication. They explain that
although the gene encoding the RNA subunit of telomerase has
been identified in a number of species, identification of the protein
components of the enzyme has been much more difficult and they
have used a genetic approach to the problem using the yeast
Saccharomyces cerevisiae as their model system. From a large
mutant screen designed to identify new mutants with a telomerase-
like defect, they identified 22 mutants that mapped to three genes
called EST1, EST2 and EST3, as well as a novel EST-like mutation
in a fourth gene previously identified as CDC13. They describe
genetic and biochemical analysis that showed EST1 and CDC13
encode single-stranded telomeric DNA binding proteins,
suggesting that these two proteins may function to mediate access
of telomerase to the end of the telomere.
Telomeres were first defined 60 years ago in the fruit fly
Drosophila melanogaster on the basis of chromosome end protec-
tion. Biessmann and colleagues describe the unusual telomere
elongation mechanism in Drosophila. Long retrotransposons HeT-
A and TART transpose to the ends of chromosomes, instead of
short repeats that are synthesized by telomerase. Evidence at the
time this chapter was written suggested that, unlike the equivalent
terminal repeats in yeast and humans, the presence and length of
terminal arrays in Drosophila may not be critical for cell cycle
progression. The authors believe that, whereas telomerase evolved
early in the evolution of eukaryotes, telomere elongation by trans-
position may be a much more recent mechanism.
The next chapter by Marcand and colleagues constitutes a very
readable review of the role of the Rap1p protein in sensing or
‘measuring’ telomere length in yeast. The authors propose a
simple negative feedback model for telomere length regulation by
Rap1p, the essence of which is the proposition that a threshold
number of Rap1 molecules bound at a telomere will generate a
signal that blocks the elongation of the telomere by telomerase.
This will eventually lead to a loss of terminal repeats and, hence, a
loss of Rap1p binding sites. When the number of Rap1p molecules
falls below the threshold value, telomerase will be active, leading
to repeat tract elongation. The role of two Rap1p interacting
factors Rif1p and Rif2p in mediating telomere length regulation
are also discussed.
The short account by Guarente on chromatin and ageing in yeast
and in mammals seems to pose more questions than it answers,
whereas the article by Sydney Shall is an interesting review of
what constitutes the limited lifespan of cells in culture.
Harley outlines the telomere hypothesis of ageing and immor-
talization, i.e. that sufficient telomere loss in one or more chromo-
somes in normal somatic cells triggers cell senescence whereas
reactivation of telomeres is necessary for cell immortalization.
Some interesting points are made in the next chapter, which is the
General Discussion on whether telomeres are correlative or
causative in cellular senescence.
The chapter by Shay and colleagues, which is the first in-depth
review on cancer in the volume, describes telomerase assays in
diagnosis and prognosis. It is clear from the information presented
that telomerase activity can be identified in the vast majority of
malignant cancers, but the authors point out that the key clinical
challenge is to determine if the level of telomerase activity has
diagnostic or prognostic utility. The suggestion is that telomerase
activity levels may identify patients that will have either favourable
or poor prognostic outcomes, whereas in other instances telomerase
activity can distinguish between benign and malignant lesions.
However, some questions remain unanswered as telomerase
activity has been found in cells adjacent to malignant tumours and
telomerase is present in a variety of dividing normal cells.
Blasco and colleagues describe mouse models to study the
expression of telomerase in tumours. They used two different
transgenic mouse models of multistage tumorigenesis and
telomerase activity was detected only in late-stage tumours. The
development of a telomerase knock-out mouse is also described,
but further results were not available at this time.
Newbold addresses a couple of key questions relating to replica-
tive senescence: (i) do genes exist in the normal human genome
whose job it is to repress telomerase in normal human cells and, if
so, are they functionally inactive in primary human cancer? and
(ii) do rodent cells differ fundamentally from the human equiva-
lent with respect to the somatic control of telomerase activity? He
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Article no. bjoc.1998.0160shows evidence to support that normal diploid human somatic
cells are resistant to immortalization because of a strongly
repressed telomerase activity. Telomerase in hamster cells appears
to be much less stringently down-regulated, thus increasing their
susceptibility to immortalization and malignant transformation.
In a short article on repair and processing events at DNA ends,
Lindahl and colleagues remind the reader that cell nuclei contain
several abundant enzymes that bind rapidly and avidly to exposed
termini of DNA. These include poly(ADP-ribose) polymerase,
DNA-dependent protein kinase, several DNA ligases and exci-
sion-repair enzymes. Telomeres are normally shielded from these
activities by telomere binding proteins but the authors point out
that, if incomplete protection of telomeres occurred, the functions
of DNA-specific enzymes would be relevant for processing of
telomeres, suggesting possible alternative pathways for telomere
propogation in telomerase-negative cells.
The final article in the book by Lansdorp et al demonstrates that
even though telomeres shorten with replication and with age the
role of telomeres in the biology of human haemopoietic stem cells
at this juncture is unclear.
The volume concludes with the final general discussion section
discussing telomeres and telomerase in other organisms and with
the summary from the chairman of the symposium, Sydney
Brenner. It is clear from this volume that the telomerase story is
still not straightforward and this volume certainly focuses on many
of the complexities. Although an extremely interesting and
thought-provoking read, the field is advancing at such a rapid pace
it is impossible for such a volume to remain up to date.
Nevertheless, I found it to be both informative and stimulating and
would recommend it as background reading for anyone who is
considering working in the area of telomerase in relation to cancer
diagnosis, prognosis or therapy. 
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